Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 713 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Kalaris Therapeutics Inc
Market Cap
$62.54M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$63.23M
Operating Margin
-69.62%
TTM Avg
-71.11%
3Y Avg
-78.39%
5Y Avg
-54.75%
Market Cap
$63.75M
Operating Margin
-7.19%
TTM Avg
-4.82%
3Y Avg
-64.73%
5Y Avg
-128.10%
Market Cap
$63.78M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-3242.03%
5Y Avg
-2392.63%
Market Cap
$61.18M
Operating Margin
-90740.62%
TTM Avg
-45413.43%
3Y Avg
-22706.72%
5Y Avg
-15137.81%
Market Cap
$61.14M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-72.58%
5Y Avg
-190.10%
Market Cap
$60.18M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$65.15M
Operating Margin
2.49%
TTM Avg
-12.82%
3Y Avg
-6.08%
5Y Avg
-11.76%
Market Cap
$65.26M
Operating Margin
-336.81%
TTM Avg
-194.53%
3Y Avg
-97.26%
5Y Avg
-64.84%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kalaris Therapeutics Inc (KLRS) | $62.54M | 0.00% | 0.00% | 0.00% | 0.00% |
| Alps Group Inc (ALPS)vs › | $63.23M | -69.62% | -71.11% | -78.39% | -54.75% |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.75M | -7.19% | -4.82% | -64.73% | -128.10% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 0.00% | 0.00% | -3242.03% | -2392.63% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $61.18M | -90740.62% | -45413.43% | -22706.72% | -15137.81% |
| Adicet Bio, Inc. (ACET)vs › | $61.14M | 0.00% | 0.00% | -72.58% | -190.10% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.18M | 0.00% | 0.00% | 0.00% | 0.00% |
| InterCure Ltd. (INCR)vs › | $65.15M | 2.49% | -12.82% | -6.08% | -11.76% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.26M | -336.81% | -194.53% | -97.26% | -64.84% |
| PDS Biotechnology Corporation (PDSB)vs › | $59.37M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | -1680.61% |
